Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Anhui Medical UniversityActive in the last 2 years

Yeben Qian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3145-3745; OpenAlex author ID A5048134771. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Integrated analysis of metabolic gene features and the immune microenvironment: identification of DPYD-mediated prognostic model and therapeutic targets in pan… Last author DOI 10.1186/s12876-026-04726-4↗
  2. Cholesterol biosynthesis inhibitor RO 48‑8071 inhibits pancreatic ductal adenocarcinoma cell viability by deactivating the JNK and ERK/MAPK signaling pathway. Last author DOI 10.3892/mmr.2021.12468↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haoyu Bao · 1 shared paper, 2026 · strength 0.32
  2. Shengquan Zhang · 1 shared paper, 2021 · strength 0.13
  3. Zhen Ding · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.